NSEGeneral Updates6d ago · 3 Nov 2026, 10:19 pm
General Updates
CORONA Remedies Limited · CORONA
✦ AI SummaryRegulatory
CORONA Remedies Limited has received a Demand Notice from the National Pharmaceutical Pricing Authority (NPPA) for alleged violation of Para 15 of the Drugs (Prices Control) Order, 2013, with a total demand amounting to ₹ 4,87,97,160/- including interest and penalty.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
CORONA Remedies Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
CORONAREMEDIES_03112026221846_Intimation_for_Action_Initiation_penalty.pdf
View document text
November 03, 2026
To, To,
Listing Operation Department Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla
Dalal Street, Mumbai – 400001 Complex, Bandra (East), Mumbai- 400051
(Scrip Code: 544644) (SYMBOL: CORONA)
Dear Sir / Madam,
Sub.: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, read with Para A of Part A of Schedule III thereto, we would like to inform you that the Company
has received a Demand Notice from the National Pharmaceutical Pricing Authority (“NPPA”),
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
In this regard, please find the details as required under the SEBI Master Circular HO/49/14/14(7)2025-
CFD-POD2/I/3762/2026 dated January 30, 2026, attached herewith as “Annexure A”.
You are requested to take note of the above.
Thanking you.
Your faithfully,
For CORONA Remedies Limited
Chetna Dharajiya
Company Secretary and Compliance Officer
Encl.: Annexure A
Annexure A
Details of the action/order required to be disclosed as per Regulation 30 read with Clause 20 of Para
A of Part A of Schedule III of SEBI LODR Regulations:
Sr. Particulars Details
1. Name of the authority National Pharmaceutical Pricing Authority (‘NPPA’),
Department of Pharmaceuticals, Ministry of Chemicals &
Fertilizers, Government of India.
2. Nature and details of the Demand Notice issued by NPPA in relation to the alleged
action(s) taken or order(s) violation of Para 15 of the Drugs (Prices Control) Order, 2013
passed (‘DPCO 2013’) total demand amounting to ₹ 4,87,97,160/-
including interest and penalty.
3. Date of receipt of direction November 03, 2026
or order, including any ad-
interim or interim orders, or
any other communication
from the authority
4. Details of the Issue regarding prior price approval under ‘DPCO 2013’. The
violation(s)/contravention(s) Company is currently evaluating the demand notice and will
committed or alleged to be take further steps in its interests in accordance with
committed applicable laws.
5. Impact on financial, The said Demand Notice does not have any material financial
operational or other impact on the Company.
activities of the listed entity,
quantifiable in monetary
terms to the extent possible